Session Information

 x 
My Library Virtual Library FAQ

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

    Switch to Virtual Meeting
    Enter Virtual Meeting Access Code
Filter Results:

Show Only CME Accredited Sessions

  • +

    EP08.03 - Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
    • +

      EP08.03-008 - Whether Immunotherapy Should Be Maintained or Not After Acquired Resistance in Advanced Nsclc

      Presenter: Shun Lu

      • Abstract

      Loading...

  • +

    OA11 - Optimal Patient Selection for Local Therapy in Stage IV NSCLC

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
    • +

      OA11.05 - Treatment Strategies Based on Different Oligoprogressive Patterns after Immunotherapy Resistance in Advanced NSCLC

      16:22 - 16:32  |  Presenter: Shun Lu

      • Abstract

      Loading...

  • +

    MA14 - Palliative and Supportive Care - The Forgotten Trade

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Strauss 3
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Palliative and Supportive Care
    • +

      MA14.05 - A Double-blind Phase III Trial of Denosumab Biosimilar QL1206 vs Denosumab in Bone Metastatic Tumor: Lung Cancer Cohort Data

      14:42 - 14:47  |  Presenter: Yan Huang

      • Abstract

      Loading...